VacT2BP have been shown to be effective in delivering daunorubicin, increasing the concentration of the drug in target cells and improving its antitumor efficacy, in which TLR2 activation facilitated drug delivery, and in the animal model used there was a significant decrease in tumor growth [26]. This evidence concerns the gene TLR2 and neoplasm.